Cancer drug side effect under the microscope: muscle enzyme spike studied
NCT ID NCT01248429
First seen Mar 22, 2026 · Last updated May 08, 2026 · Updated 7 times
Summary
This study looked at how often a muscle enzyme called CPK increases in people with solid tumors who are taking a type of targeted therapy called tyrosine kinase inhibitors (TKIs). Researchers measured CPK levels in 154 patients during routine blood tests. They also checked if muscle pain was linked to higher CPK levels. The goal was to better understand this side effect, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Bordeaux
Bordeaux, 33076, France
-
CHU Limoges
Limoges, 87042, France
-
CHU Robert Debré
Reims, 51092, France
-
Centre Alexis Vautrin
Vandœuvre-lès-Nancy, 54511, France
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Eugène Marquis
Rennes, 35042, France
-
Centre François Baclesse
Caen, 14076, France
-
Centre Henri Becquerel
Rouen, 76000, France
-
Centre Jean Perrin
Clermont-Ferrand, 63011, France
-
Centre Léon Bérard
Lyon, 69008, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Centre Paul Papin
Angers, 49000, France
-
Centre René Huguenin
Saint-Cloud, 92211, France
-
Centre Val d'Aurelle
Montpellier, 34298, France
-
Hôpital Cochin - APHP
Paris, 75014, France
-
Hôpital Edouard Herriot
Lyon, 69003, France
-
Hôpital Henri Mondor - APHP
Créteil, 94010, France
-
Hôpital Jean Minjoz
Besançon, 25030, France
-
Hôpital Saint-Louis - APHP
Paris, 75010, France
-
Hôpital Tenon - APHP
Paris, 75020, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Claudius Régaud
Toulouse, 31052, France
-
Institut Curie
Paris, 75248, France
-
Institut Gustave Roussy
Villejuif, 94805, France
-
Institut Jean Godinot
Reims, 51056, France
-
Institut Paoli Calmettes
Marseille, 13273, France
-
Institut de Cancérologie de la Loire
Saint-Priest-en-Jarez, 42271, France
Conditions
Explore the condition pages connected to this study.